In the fourteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the recent data on COVID-19 and children. This presentation will cover the typical presentation of COVID-19 in children and review the risk and mechanisms of Multisystem Inflammatory Syndrome in Children (MIS-C).

In the thirteenth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss recent trends in COVID-19 infection numbers and will review new findings on immune response after COVID-19 infection and the use of corticosteroids in hospitalized patients requiring mechanical ventilation or oxygen.

In the eighth episode of Pri-Med’s weekly web series on COVID-19, faculty will continue their discussion on treatment by describing immunomodulatory therapies and additional antivirals under investigation for COVID-19. They will also review the various types of vaccines currently in development for COVID-19. Specific therapies to be discussed in this episode will include: • Antivirals: baloxavir marboxil, favipiravir, nitazoxanide, oseltamivir, ribavirin, umifenovir • Glucocorticoids • Anakinra • Tocilizumab • Interferon beta-1b • Vaccine mRNA-1273 Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/21/2020 and they are subject to change as new information is published.

In the fourth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the clinical presentation and diagnosis of COVID-19. In addition to describing the various methods of COVID-19 testing, they will review data regarding the presentation of patients with COVID-19, including history, physical exam, labs, and imaging findings. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/23/2020 and they are subject to change as new information is published.

In the fifth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss strategies for adapting clinical practice to virtual platforms and explain how telehealth has changed as a result of the COVID-19 pandemic. They will review requirements for providing various types of telehealth visits (audio only vs. audio plus video) and share practical advice on getting reimbursed for these encounters, including review of common billing codes. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 4/28/2020 and they are subject to change as new information is published.

Join an expert panel hosted by primary care physician Frank Domino, MD with infectious disease experts Paul Sax, MD and Laila Woc-Colburn, MD, as they answer your COVID-19 questions. In addition to answering live questions from the audience, faculty will share their clinical experiences, and discuss the most relevant updates in the literature and current recommendations regarding COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/08/2020 and they are subject to change as new information is published.

In the second episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss the risks to healthcare workers associated with COVID-19. They will review current data on systems-based solutions to reduce transmission risk, the importance of personal protective equipment (PPE), and when to discontinue precautions in patients with resolved COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/09/2020, and they are subject to change as new information is published.

In the first episode of Pri-Med’s weekly web series on COVID-19, faculty will review the unique aspects of COVID-19’s spread and impact, including the epidemiology, viral characteristics, common clinical manifestations and complications of infection. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 3/31/2020 and they are subject to change as new information is published.

In the third episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss important information for clinicians to relay to their patients regarding COVID-19. They will review current recommendations around how patients should be instructed to protect themselves and high-risk family members, how to monitor symptoms when sick, and how to determine when it’s appropriate to end self-isolation. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 04/16/2020 and they are subject to change as new information is published.

In the sixth episode of Pri-Med’s weekly web series on COVID-19, faculty will interview a patient who recently recovered from COVID-19. This patient will share his experience from diagnosis to recovery, including thoughts on his interaction with the healthcare system during this unique time. This session aims to give clinicians a better understanding of the patient perspective, and helps us recognize where there is potential for improvement in caring for patients with COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/07/2020 and they are subject to change as new information is published.

In the seventh episode of Pri-Med’s weekly web series on COVID-19, faculty will start off a multi-episode spanning discussion on COVID-19 treatment by analyzing recent evidence of antiviral therapies. They will also review the current recommendations regarding their use in patients with COVID-19. Therapies to be discussed in this episode will include: • Convalescent Plasma • Camostat Mesilate • Lopinavir/Ritonavir • Hydroxychloroquine and Chloroquine • Remdesivir Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 05/14/2020 and they are subject to change as new information is published.

In the ninth episode of Pri-Med’s weekly web series on COVID-19, faculty will discuss ongoing treatment considerations and controversies. They will review the potential role of steroids and vitamins in treating and preventing COVID-19, as well as the safety of commonly used medications including ibuprofen, ARBs, and ACE inhibitors in patients with or at risk for COVID-19. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 5/28/2020 and they are subject to change as new information is published.